Impact of carcinoid syndrome symptoms and long-term use of somatostatin analogs on quality of life in patients with carcinoid syndrome: A survey study

To evaluate association of carcinoid syndrome (CS) symptom burden and somatostatin analog (SSA) duration with quality of life (QoL) using Functional Assessment of Cancer Therapy-General (FACT-G) and Patient-Reported Outcomes Measurement Information System (PROMIS-29) instruments. Adults who received...

Descripción completa

Detalles Bibliográficos
Autores principales: Halperin, Daniel M., Huynh, Lynn, Beaumont, Jennifer L., Cai, Beilei, Totev, Todor, Bhak, Rachel H., Duh, Mei S., Neary, Maureen P., Cella, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392719/
https://www.ncbi.nlm.nih.gov/pubmed/30461659
http://dx.doi.org/10.1097/MD.0000000000013390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392719/
https://www.ncbi.nlm.nih.gov/pubmed/30461659
http://dx.doi.org/10.1097/MD.0000000000013390

Ejemplares similares